Please enable JavaScript to continue using this application.

Compare $INDP vs $USBC | Chartloom

Compare

$INDP vs $USBC

Indaptus Therapeutics Inc · USBC Inc

INDP

Indaptus Therapeutics Inc

USBC

USBC Inc

Compare $INDP vs $USBC

Comparing Indaptus Therapeutics Inc and USBC Inc

INDPIndaptus Therapeutics Inc

USBCUSBC Inc

INDPIndaptus Therapeutics Inc

Market cap

$284M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-8.4%

52W performance

-42.7%

FCF yield

-5.2%

USBCUSBC Inc

Market cap

$198M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-51.9%

FCF yield

-11.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INDP

USBC

Detailed metrics comparison

INDP

Indaptus Therapeutics Inc

USBC

USBC Inc

Market Cap

INDP$284M

USBC$198M

Enterprise Value

INDP$277M

USBC$210M

Price

INDP$2.51

USBC$0.51

P/E Ratio

INDPN/A

USBCN/A

P/S Ratio

INDP0.00x

USBC0.00x

EV/Sales

INDP0.00x

USBC0.00x

EV/EBITDA

INDP0.00x

USBC0.00x

P/B Ratio

INDP32.14x

USBC4.46x

P/FCF Ratio

INDPN/A

USBCN/A

EV/FCF

INDP-18.83x

USBC-9.14x

PEG Ratio

INDPN/A

USBCN/A

Forward P/E (NTM)

INDPN/A

USBCN/A

Forward P/S (NTM)

INDPN/A

USBCN/A

Revenue (TTM)

INDP$0

USBC$0

Revenue Growth (YoY)

INDPN/A

USBCN/A

Forward Rev Growth

INDP0.0%

USBC0.0%

Gross Margin (TTM)

INDP0.0%

USBC0.0%

Operating Margin (TTM)

INDP0.0%

USBC0.0%

EBITDA Margin (TTM)

INDP0.0%

USBC0.0%

Net Margin (TTM)

INDP0.0%

USBC0.0%

FCF Margin (TTM)

INDPN/A

USBCN/A

Net Income (TTM)

INDP$-15M

USBC$-86M

FCF (TTM)

INDP$-15M

USBC$-23M

EPS (TTM)

INDP-$0.13

USBC-$0.22

ROE (TTM)

INDP-30275.0%

USBC-12093.0%

ROA (TTM)

INDP-20348.0%

USBC-9639.0%

ROIC (TTM)

INDP-30275.0%

USBC-11297.0%

Cash

INDP$8M

USBC$3M

Debt

INDP$0

USBC$15M

Net Cash/Debt

INDP$8M

USBC$-12M

Current Ratio (TTM)

INDP19.48x

USBC0.23x

Quick Ratio (TTM)

INDP18.82x

USBC0.20x

Debt/Equity (TTM)

INDP0.00x

USBC0.32x

Debt/Assets (TTM)

INDP0.0%

USBC0.0%

Interest Coverage (TTM)

INDPN/A

USBCN/A

Net Debt/EBITDA (TTM)

INDP0.00x

USBC0.00x

Beta

INDP0.99

USBC2.77

52W Performance

INDP-42.7%

USBC-51.9%

YTD Performance

INDP-8.4%

USBC-22.2%

% from 52W High

INDP-57.9%

USBC-60.5%

% from 52W Low

INDP172.8%

USBC78.7%

Asset Turnover (TTM)

INDP0.00x

USBC0.00x

FCF Yield (TTM)

INDP-5.2%

USBC-11.6%

Earnings Yield (TTM)

INDP-5.4%

USBC-43.5%

Dividend Yield (TTM)

INDPN/A

USBCN/A

Rule of 40

INDP0.0

USBC0.0

EV/GP/RG

INDPN/A

USBCN/A

Ticker research

View INDP research View USBC research

Metric	INDP Indaptus Therapeutics Inc	USBC USBC Inc
Market & Valuation
Market Cap	$284M	$198M
Enterprise Value	$277M	$210M
Price	$2.51	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	32.14x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.83x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-15M	$-86M
FCF (TTM)	$-15M	$-23M
EPS (TTM)	-$0.13	-$0.22
ROE (TTM)	-30275.0%	-12093.0%
ROA (TTM)	-20348.0%	-9639.0%
ROIC (TTM)	-30275.0%	-11297.0%
Financial Health
Cash	$8M	$3M
Debt	$0	$15M
Net Cash/Debt	$8M	$-12M
Current Ratio (TTM)	19.48x	0.23x
Quick Ratio (TTM)	18.82x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	2.77
52W Performance	-42.7%	-51.9%
YTD Performance	-8.4%	-22.2%
% from 52W High	-57.9%	-60.5%
% from 52W Low	172.8%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.2%	-11.6%
Earnings Yield (TTM)	-5.4%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INDP research	View USBC research

Valuation

P/S Ratio

INDP

0.00x

USBC

0.00x

EV/FCF

INDP

-18.83x

USBC

-9.14x

Growth & revenue

Forward Revenue Growth

INDP

0.0%

USBC

0.0%

Profitability & performance

Gross Margin

INDP

0.0%

USBC

0.0%

ROE

USBC

-12093.0%

INDP

-30275.0%

FCF Yield %

INDP

-5.2%

USBC

-11.6%

52-Week Performance

INDP

-42.7%

USBC

-51.9%

Detailed metrics comparison

INDP

Indaptus Therapeutics Inc

USBC

USBC Inc

Market Cap

INDP$284M

USBC$198M

Enterprise Value

INDP$277M

USBC$210M

Price

INDP$2.51

USBC$0.51

P/E Ratio

INDPN/A

USBCN/A

P/S Ratio

INDP0.00x

USBC0.00x

EV/Sales

INDP0.00x

USBC0.00x

EV/EBITDA

INDP0.00x

USBC0.00x

P/B Ratio

INDP32.14x

USBC4.46x

P/FCF Ratio

INDPN/A

USBCN/A

EV/FCF

INDP-18.83x

USBC-9.14x

PEG Ratio

INDPN/A

USBCN/A

Forward P/E (NTM)

INDPN/A

USBCN/A

Forward P/S (NTM)

INDPN/A

USBCN/A

Revenue (TTM)

INDP$0

USBC$0

Revenue Growth (YoY)

INDPN/A

USBCN/A

Forward Rev Growth

INDP0.0%

USBC0.0%

Gross Margin (TTM)

INDP0.0%

USBC0.0%

Operating Margin (TTM)

INDP0.0%

USBC0.0%

EBITDA Margin (TTM)

INDP0.0%

USBC0.0%

Net Margin (TTM)

INDP0.0%

USBC0.0%

FCF Margin (TTM)

INDPN/A

USBCN/A

Net Income (TTM)

INDP$-15M

USBC$-86M

FCF (TTM)

INDP$-15M

USBC$-23M

EPS (TTM)

INDP-$0.13

USBC-$0.22

ROE (TTM)

INDP-30275.0%

USBC-12093.0%

ROA (TTM)

INDP-20348.0%

USBC-9639.0%

ROIC (TTM)

INDP-30275.0%

USBC-11297.0%

Cash

INDP$8M

USBC$3M

Debt

INDP$0

USBC$15M

Net Cash/Debt

INDP$8M

USBC$-12M

Current Ratio (TTM)

INDP19.48x

USBC0.23x

Quick Ratio (TTM)

INDP18.82x

USBC0.20x

Debt/Equity (TTM)

INDP0.00x

USBC0.32x

Debt/Assets (TTM)

INDP0.0%

USBC0.0%

Interest Coverage (TTM)

INDPN/A

USBCN/A

Net Debt/EBITDA (TTM)

INDP0.00x

USBC0.00x

Beta

INDP0.99

USBC2.77

52W Performance

INDP-42.7%

USBC-51.9%

YTD Performance

INDP-8.4%

USBC-22.2%

% from 52W High

INDP-57.9%

USBC-60.5%

% from 52W Low

INDP172.8%

USBC78.7%

Asset Turnover (TTM)

INDP0.00x

USBC0.00x

FCF Yield (TTM)

INDP-5.2%

USBC-11.6%

Earnings Yield (TTM)

INDP-5.4%

USBC-43.5%

Dividend Yield (TTM)

INDPN/A

USBCN/A

Rule of 40

INDP0.0

USBC0.0

EV/GP/RG

INDPN/A

USBCN/A

Ticker research

View INDP research View USBC research

Metric	INDP Indaptus Therapeutics Inc	USBC USBC Inc
Market & Valuation
Market Cap	$284M	$198M
Enterprise Value	$277M	$210M
Price	$2.51	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	32.14x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.83x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-15M	$-86M
FCF (TTM)	$-15M	$-23M
EPS (TTM)	-$0.13	-$0.22
ROE (TTM)	-30275.0%	-12093.0%
ROA (TTM)	-20348.0%	-9639.0%
ROIC (TTM)	-30275.0%	-11297.0%
Financial Health
Cash	$8M	$3M
Debt	$0	$15M
Net Cash/Debt	$8M	$-12M
Current Ratio (TTM)	19.48x	0.23x
Quick Ratio (TTM)	18.82x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	2.77
52W Performance	-42.7%	-51.9%
YTD Performance	-8.4%	-22.2%
% from 52W High	-57.9%	-60.5%
% from 52W Low	172.8%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.2%	-11.6%
Earnings Yield (TTM)	-5.4%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INDP research	View USBC research